stabilizes accumulations of adeno-associated virus virions at the perinuclear region, increasing transduction in vitro and in vivo.
Use of arsenic trioxide
(As203) in the treatment of acute promyelocytic leukemia (APL): II.
They are now the first to inhibit this pathway by arsenic trioxide
in ES, and among the first to show its activity in medulloblastoma.
INDUCTION PROFILE AND CELLULAR RESPONSE MECHANISMS OF HUMAN LIVER CARCINOMA CELL (HEPG2) LINE TREATED WITH ARSENIC TRIOXIDE
, CADMIUM CHLORIDE, AND 2,4,6-TRINITROTOLUENE
promotes histone H3 phosphoacetylation at the chromatin of CASPASE-10 in acute promyelocytic leukemia cells.
Food and Drug Administration has already approved arsenic trioxide
for use in humans, which could pave the way for clinical trials of this approach.
Efficacy of a potentized homoeopathic drug (Arsenicum Album-30) in reducing genotoxic effects produced by arsenic trioxide
in mice: comparative studies of pre-, post- and combined pre- and post-oral administration and comparative efficacy of two microdoses.
The findings from the phone survey included use of arsenic, arsenic trioxide
, asbestos, benzene, lead chromate, sodium arsenate, and sodium dichromate in pure form for science or chemistry experiments or demonstrations.
in hematological malignancies: the new discovery of an ancient drug.
Involvement of mitChondrial aggregation in arsenic trioxide
(As2O3)-induced apoptosis in human glioblastoma cells.